Vitamin Shoppe (VSI) Misses Q1 EPS by 11c; Trims FY15 EPS Outlook; Approves Common Buyback Plan

Vitamin Shoppe (NYSE: VSI) reported Q1 EPS of $0.63, $0.11 worse than the analyst estimate of $0.74. Revenue for the quarter came in at $336.8 million versus the consensus estimate of $344.66 million. Total comparable sales of 1.2%

The Board of Directors has authorized another share repurchase program that enables the company to purchase an additional $100 million of its shares of common stock over the next three years. Shares will be repurchased from time-to-time in the open market or in privately negotiated transactions. The repurchase program does not obligate the Company to acquire any specific number of shares and may be suspended, terminated or modified at any time for any reason, including market conditions, the cost of repurchasing shares, the availability of alternative investment opportunities, liquidity, and other factors deemed appropriate. These factors may also affect the timing and amount of share repurchases.

Vitamin Shoppe sees FY2015 EPS of $2.05-$2.25, versus the consensus of $2.40.

For earnings history and earnings-related data on Vitamin Shoppe (VSI) click here.

You May Also Be Interested In

• Discover Financial Services reports mixed Q1 results as earnings fall short
• William Penn Bancorporation (WMPN) Tops Q3 EPS by 1c
• Liberty Oilfield Services (LBRT) Misses Q1 EPS by 6c, provides outlook